C-MYC-Independent Nuclear Reprogramming Favors Cardiogenic Potential of Induced Pluripotent Stem Cells

Journal of Cardiovascular Translational Research

Volumn 3, Issue 1, 2010, Pages 13-23

  Martinez Fernandez, Almudena ^a   Nelson, Timothy J ^a   Ikeda, Yasuhiro ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac; Differentiation; Heart; Induced Pluripotent Stem Cells; IPS; Oncogene

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; FIBROBLAST GROWTH FACTOR 4; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; MYOCARDIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEF2C; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX7; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; KRUPPEL LIKE FACTOR; MYC PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL GROWTH; CELL REGENERATION; CELL STRUCTURE; CHIMERA; CLONE; EMBRYO; FGF4 GENE; FIBROBLAST; GENE; GENE EXPRESSION; GROWTH RATE; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGENY; REGENERATIVE MEDICINE; SARCOMERE; UPREGULATION; ANIMAL; CELL CULTURE; CELL LINEAGE; EMBRYO CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HEART MUSCLE CELL; HUMAN; METABOLISM; TIME;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EMBRYO CULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MYOCYTES, CARDIAC; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; TIME FACTORS; TRANSDUCTION, GENETIC; CELLULAR REPROGRAMMING;

IPS;

EID: 75949123106     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9150-5     Document Type: Article

References (47)

1. S Yamanaka 2007 Strategies and new developments in the generation of patient-specific pluripotent stem cells Cell Stem Cell 1 1 39 49 10.1016/j.stem.2007.05.012 1:CAS:528:DC%2BD2sXptV2rsrk%3D 18371333 (Pubitemid 46865811)
2. K Takahashi K Okita M Nakagawa S Yamanaka 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 663 676 10.1016/j.cell.2006.07.024 1:CAS:528:DC%2BD28Xpt1aktbs%3D 16904174 (Pubitemid 44233629)
3. K Okita T Ichisaka S Yamanaka 2007 Generation of germ line-competent induced pluripotent stem cells Nature 448 7151 313 317 10.1038/nature05934 1:CAS:528:DC%2BD2sXnvVeqsL0%3D 17554338 (Pubitemid 47080336)
4. TJ Nelson AJ Martinez-Fernandez S Yamada AA Mael A Terzic Y Ikeda 2009 Induced pluripotent reprogramming from promiscuous human stemness-related factors Clinical and Translational Science 2 2 118 126 10.1111/j.1752-8062.2009. 00091.x
5. M Wernig A Meissner R Foreman T Brambrink M Ku K Hochedlinger, et al. 2007 In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 448 7151 318 324 10.1038/nature05944 1:CAS:528:DC%2BD2sXnvVeqsLg%3D 17554336 (Pubitemid 47080337)
6. J Yu MA Vodyanik K Smuga-Otto J Antosiewicz-Bourget JL Frane S Tian, et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells Science 318 5858 1917 1920 10.1126/science.1151526 1:CAS:528:DC%2BD2sXhsVGjsLbN 18029452
7. K Hochedlinger K Plath 2009 Epigenetic reprogramming and induced pluripotency Development 136 4 509 523 10.1242/dev.020867 1:CAS:528: DC%2BD1MXjsFKgt7Y%3D 19168672
8. S Nishikawa RA Goldstein CR Nierras 2008 The promise of human induced pluripotent stem cells for research and therapy Nature Reviews Molecular Cell Biology 9 9 725 729 10.1038/nrm2466 1:CAS:528:DC%2BD1cXhtVWgu7jE 18698329
9. IH Park N Arora H Huo N Maherali T Ahfeldt A Shimamura, et al. 2008 Disease-specific induced pluripotent stem cells Cell 134 5 877 886 10.1016/j.cell.2008.07.041 1:CAS:528:DC%2BD1cXhtFCqs7bK 18691744
10. J Hanna M Wernig S Markoulaki CW Sun A Meissner JP Cassady, et al. 2007 Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science 318 5858 1920 1923 10.1126/science.1152092 1:CAS:528:DC%2BD2sXhsVGjsLbP 18063756
11. M Wernig JP Zhao J Pruszak E Hedlund D Fu F Soldner, et al. 2008 Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 105 14 5856 5861 10.1073/pnas.0801677105 1:CAS:528:DC%2BD1cXltVyis70%3D 18391196 (Pubitemid 351758462)
12. D Xu Z Alipio LM Fink DM Adcock J Yang DC Ward, et al. 2009 Phenotypic correction of murine hemophilia A using an iPS cell-based therapy Proceedings of the National Academy of Sciences of the United States of America 106 3 808 813 10.1073/pnas.0812090106 1:CAS:528:DC%2BD1MXht12isb0%3D 19139414
13. TJ Nelson A Martinez-Fernandez S Yamada C Perez-Terzic Y Ikeda A Terzic 2009 Repair of acute myocardial infarction with human stemness factors induced pluripotent stem cells Circulation 120 5 408 416 10.1161/CIRCULATIONAHA.109. 865154 19620500
14. K Schenke-Layland KE Rhodes E Angelis Y Butylkova S Heydarkhan-Hagvall C Gekas, et al. 2008 Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages Stem Cells 26 6 1537 1546 10.1634/stemcells.2008-0033 1:CAS:528:DC%2BD1cXotFGhtbo%3D 18450826
15. C Mauritz K Schwanke M Reppel S Neef K Katsirntaki LS Maier, et al. 2008 Generation of functional murine cardiac myocytes from induced pluripotent stem cells Circulation 118 5 507 517 10.1161/CIRCULATIONAHA.108.778795 18625890
16. G Narazaki H Uosaki M Teranishi K Okita B Kim S Matsuoka, et al. 2008 Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells Circulation 118 5 498 506 10.1161/CIRCULATIONAHA. 108.769562 18625891
17. J Zhang G Wilson A Soerens C Koonce J Yu S Palecek, et al. 2009 Functional cardiomyocytes derived from human induced pluripotent stem cells Circulation Research 104 4 e30 e41 10.1161/CIRCRESAHA.108.192237 1:CAS:528:DC%2BD1MXhvFejtb4%3D 19213953
18. A Martinez-Fernandez TJ Nelson S Yamada S Reyes AE Alekseev C Perez-Terzic, et al. 2009 iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism Circulation Research 105 7 648 656 10.1161/CIRCRESAHA.109.203109 1:CAS:528:DC%2BD1MXhtFelsr3O 19696409
19. JT Dimos KT Rodolfa KK Niakan LM Weisenthal H Mitsumoto W Chung, et al. 2008 Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 5893 1218 1221 10.1126/science.1158799 1:CAS:528:DC%2BD1cXhtVGgt7zL 18669821
20. A Raya I Rodríguez-Pizà G Guenechea R Vassena S Navarro MJ Barrero, et al. 2009 Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 7251 53 59 10.1038/nature08129 1:CAS:528:DC%2BD1MXms1aktLo%3D 19483674
21. R Maehr S Chen M Snitow T Ludwig L Yagasaki R Goland RL Leibel DA Melton 2009 Generation of pluripotent stem cells from patients with type 1 diabetes Proceedings of the National Academy of Sciences of the United States of America 106 37 15768 15773 10.1073/pnas.0906894106 1:CAS:528:DC%2BD1MXhtFyjsLbP 19720998
22. G Lee EP Papapetrou H Kim SM Chambers MJ Tomishima CA Fasano, et al. 2009 Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs Nature 461 7262 402 406 10.1038/nature08320 1:CAS:528:DC%2BD1MXhtVWhsbjL 19693009
23. KR Chien IJ Domian KK Parker 2008 Cardiogenesis and the complex biology of regenerative cardiovascular medicine Science 322 5907 1494 1497 10.1126/science.1163267 1:CAS:528:DC%2BD1cXhsVGltbzN 19056974
24. C Perez-Terzic RS Faustino BJ Boorsma DK Arrell NJ Niederländer A Behfar, et al. 2007 Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery Nature Clinical Practice Cardiovascular Medicine 4 Suppl 1 S68 S76 10.1038/ncpcardio0763 1:CAS:528:DC%2BD2sXitVemtbg%3D 17230218 (Pubitemid 46151907)
25. C Perez-Terzic A Behfar A Méry JM van Deursen A Terzic M Pucéat 2003 Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes Circulation Research 92 4 444 452 10.1161/01.RES.0000059415.25070.54 1:CAS:528:DC%2BD3sXhsValtbk%3D 12600892 (Pubitemid 36298205)
26. TJ Nelson A Martinez-Fernandez A Terzic 2009 KCNJ11 knockout morula reengineered by stem cell diploid aggregation Philosophical Transactions of the Royal Society London B: Biological Sciences 364 1514 269 276 10.1098/rstb.2008.0179 1:CAS:528:DC%2BD1MXivFSltLY%3D
27. A Behfar C Perez-Terzic RS Faustino DK Arrell DM Hodgson S Yamada, et al. 2007 Cardiopoietic programming of embryonic stem cells for tumor-free heart repair Journal of Experimental Medicine 204 2 405 420 10.1084/jem.20061916 1:CAS:528:DC%2BD2sXitVektLY%3D 17283208 (Pubitemid 46294555)
28. + progenitors is associated with divergent Sox7 expression in cardiopoiesis Differentiation 77 3 248 255 10.1016/j.diff.2008.10.012 1:CAS:528:DC%2BD1MXjvFamsLw%3D 19272523
29. DM Hodgson A Behfar LV Zingman GC Kane C Perez-Terzic AE Alekseev, et al. 2004 Stable benefit of embryonic stem cell therapy in myocardial infarction American Journal of Physiology Heart and Circulatory Physiology 287 2 H471 H479 10.1152/ajpheart.01247.2003 1:CAS:528:DC%2BD2cXmvFalurk%3D 15277190 (Pubitemid 38955274)
30. N Maherali K Hochedlinger 2008 Guidelines and techniques for the generation of induced pluripotent stem cells Cell Stem Cell 3 6 595 605 10.1016/j.stem.2008.11.008 1:CAS:528:DC%2BD1cXhsFCqsLjP 19041776
31. S Yamanaka 2008 Pluripotency and nuclear reprogramming Philosophical Transactions of the Royal Society London B: Biological Science 363 1500 2079 2087 10.1098/rstb.2008.2261 1:CAS:528:DC%2BD1cXosVCqsr8%3D (Pubitemid 351693523)
32. S Yamanaka 2009 Elite and stochastic models for induced pluripotent stem cell generation Nature 460 7251 49 52 10.1038/nature08180 1:CAS:528: DC%2BD1MXotVSgu7c%3D 19571877
33. JB Kim V Sebastiano G Wu MJ Araúzo-Bravo P Sasse L Gentile, et al. 2009 Oct4-induced pluripotency in adult neural stem cells Cell 136 3 411 419 10.1016/j.cell.2009.01.023 1:CAS:528:DC%2BD1MXltFSnsr4%3D 19203577
34. M Nakagawa M Koyanagi K Tanabe K Takahashi T Ichisaka T Aoi, et al. 2008 Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nature Biotechnology 26 1 101 106 10.1038/nbt1374 1:CAS:528:DC%2BD1cXisFGmuw%3D%3D 18059259
35. M Wernig A Meissner JP Cassady R Jaenisch 2008 c-Myc is dispensable for direct reprogramming of mouse fibroblasts Cell Stem Cell 2 1 10 12 10.1016/j.stem.2007.12.001 1:CAS:528:DC%2BD1cXhtFOltrc%3D 18371415
36. Y Guo C Niu P Breslin M Tang S Zhang W Wei, et al. 2009 c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors Blood 114 10 2097 2106 10.1182/blood-2009-01-197947 1:CAS:528:DC%2BD1MXhtFKksLrP 19372257
37. S Izumo B Nadal-Ginard V Mahdavi 1988 Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload Proceedings of the National Academy of Sciences of the United States of America 85 2 339 343 10.1073/pnas.85.2.339 1:CAS:528:DyaL1cXhtVOgt7Y%3D 2963328
38. TA Baudino C McKay H Pendeville-Samain JA Nilsson KH Maclean EL White, et al. 2002 c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression Genes and Development 16 19 2530 2543 10.1101/gad.1024602 1:CAS:528:DC%2BD38XnvVGjt7g%3D 12368264
39. T Jackson MF Allard CM Sreenan LK Doss SP Bishop JL Swain 1990 The c-myc proto-oncogene regulates cardiac development in transgenic mice Molecular Cell Biology 10 7 3709 3716 1:CAS:528:DyaK3cXksFKgurs%3D
40. G Xiao S Mao G Baumgarten J Serrano MC Jordan KP Roos, et al. 2001 Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis Circulation Research 89 12 1122 1129 10.1161/hh2401.100742 1:CAS:528:DC%2BD3MXptFKgtLc%3D 11739276
41. W Zhong S Mao S Tobis E Angelis MC Jordan KP Roos, et al. 2006 Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway EMBO Journal 25 16 3869 3879 10.1038/sj.emboj.7601252 1:CAS:528:DC%2BD28XovVSqurY%3D 16902412 (Pubitemid 44300272)
42. BL Kidder J Yang S Palmer 2008 Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells PLoS ONE 3 12 e3932 10.1371/journal.pone. 0003932 19079543
43. T Brambrink R Foreman GG Welstead CJ Lengner M Wernig H Suh, et al. 2008 Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells Cell Stem Cell 2 2 151 159 10.1016/j.stem.2008.01.004 1:CAS:528:DC%2BD1cXitlygtbw%3D 18371436 (Pubitemid 351168714)
44. TJ Nelson A Behfar A Terzic 2008 Stem cells: biologics for regeneration Clinical Pharmacology and Therapeutics 84 5 620 623 10.1038/clpt.2008.146 1:CAS:528:DC%2BD1cXht1OisLvK 18701884
45. TJ Nelson A Behfar A Terzic 2008 Strategies for therapeutic repair: the "R3" regenerative medicine paradigm Clinical and Translational Science 1 2 168 171 10.1111/j.1752-8062.2008.00039.x 19756244
46. TJ Nelson A Behfar S Yamada A Martinez-Fernandez A Terzic 2009 Stem cell platforms for regenerative medicine Clinical and Translational Science 2 3 222 227 10.1111/j.1752-8062.2009.00096.x 19779576
47. JA Byrne HN Nguyen RA Reijo Pera 2009 Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts PLoS ONE 4 9 e7118 10.1371/journal.pone.0007118 19774082